Sonnenblick A - Search Results

1

[Update: adjuvant trastuzumab in HER2 positive breast cancer].

Tahover E, Sonnenblick A, Peretz T, Katz D. Tahover E, et al. Among authors: sonnenblick a. Harefuah. 2012 Jan;151(1):37-42, 61. Harefuah. 2012. PMID: 22670500 Review. Hebrew.

2

Liver failure on the background of pseudocirrhosis in patients with liver metastasis from breast cancer, who responded to treatment.

Sonnenblick A, Appelbaum L, Peretz T. Sonnenblick A, et al. Onkologie. 2011;34(4):199-201. doi: 10.1159/000327010. Epub 2011 Mar 23. Onkologie. 2011. PMID: 21447980 No abstract available.

3

Complete remission, in BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma, treated with cisplatin based therapy.

Sonnenblick A, Kadouri L, Appelbaum L, Peretz T, Sagi M, Goldberg Y, Hubert A. Sonnenblick A, et al. Cancer Biol Ther. 2011 Aug 1;12(3):165-8. doi: 10.4161/cbt.12.3.16292. Epub 2011 Aug 1. Cancer Biol Ther. 2011. PMID: 21613821 Free article.

4

Tissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is a marker of good prognosis.

Sonnenblick A, Shriki A, Galun E, Axelrod JH, Daum H, Rottenberg Y, Hamburger T, Mali B, Peretz T. Sonnenblick A, et al. Clin Transl Oncol. 2012 Mar;14(3):232-6. doi: 10.1007/s12094-012-0789-z. Clin Transl Oncol. 2012. PMID: 22374428

5

Long-term outcome of continuous 5-fluorouracil/cisplatin-based chemotherapy followed by chemoradiation in patients with resected gastric cancer.

Sonnenblick A, Rottenberg Y, Kadouri L, Wygoda M, Rivkind A, Vainer GW, Peretz T, Hubert A. Sonnenblick A, et al. Med Oncol. 2012 Dec;29(5):3035-8. doi: 10.1007/s12032-012-0302-0. Epub 2012 Jul 8. Med Oncol. 2012. PMID: 22773040 Clinical Trial.

6

Tumor STAT3 tyrosine phosphorylation status, as a predictor of benefit from adjuvant chemotherapy for breast cancer.

Sonnenblick A, Uziely B, Nechushtan H, Kadouri L, Galun E, Axelrod JH, Katz D, Daum H, Hamburger T, Maly B, Allweis TM, Peretz T. Sonnenblick A, et al. Breast Cancer Res Treat. 2013 Apr;138(2):407-13. doi: 10.1007/s10549-013-2453-x. Epub 2013 Feb 28. Breast Cancer Res Treat. 2013. PMID: 23446809

7

Gemcitabine in combination with paclitaxel for advanced soft-tissue sarcomas.

Sonnenblick A, Eleyan F, Peretz T, Ospovat I, Merimsky O, Sella T, Peylan-Ramu N, Katz D. Sonnenblick A, et al. Mol Clin Oncol. 2015 Jul;3(4):829-832. doi: 10.3892/mco.2015.545. Epub 2015 Apr 16. Mol Clin Oncol. 2015. PMID: 26171190 Free PMC article.

8

Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer.

Sonnenblick A, Brohée S, Fumagalli D, Vincent D, Venet D, Ignatiadis M, Salgado R, Van den Eynden G, Rothé F, Desmedt C, Neven P, Loibl S, Denkert C, Joensuu H, Loi S, Sirtaine N, Kellokumpu-Lehtinen PL, Piccart M, Sotiriou C. Sonnenblick A, et al. BMC Med. 2015 Aug 3;13:177. doi: 10.1186/s12916-015-0416-2. BMC Med. 2015. PMID: 26234940 Free PMC article.

9

Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model.

Zahavi T, Lanton T, Divon MS, Salmon A, Peretz T, Galun E, Axelrod JH, Sonnenblick A. Zahavi T, et al. Among authors: sonnenblick a. Oncotarget. 2016 Jan 26;7(4):4860-70. doi: 10.18632/oncotarget.6638. Oncotarget. 2016. PMID: 26695439 Free PMC article.

10

Metastatic breast cancer: The Odyssey of personalization.

Sonnenblick A, Pondé N, Piccart M. Sonnenblick A, et al. Mol Oncol. 2016 Oct;10(8):1147-59. doi: 10.1016/j.molonc.2016.07.002. Epub 2016 Jul 11. Mol Oncol. 2016. PMID: 27430154 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters